Taken together, our results show that in addition to rearranging the domain order of bsDbs, increasing their binding affinity may be an ideal strategy for enhancing the cytotoxicity of anti-parallel constructs and that E2x3-LH is attractive as a candidate next-generation anti-cancer drug. This evidence concerns the gene PLOD1 and cancer.